JP2023504560A5 - - Google Patents

Info

Publication number
JP2023504560A5
JP2023504560A5 JP2022533605A JP2022533605A JP2023504560A5 JP 2023504560 A5 JP2023504560 A5 JP 2023504560A5 JP 2022533605 A JP2022533605 A JP 2022533605A JP 2022533605 A JP2022533605 A JP 2022533605A JP 2023504560 A5 JP2023504560 A5 JP 2023504560A5
Authority
JP
Japan
Prior art keywords
cell
kit
antigen
promoter
cell according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022533605A
Other languages
English (en)
Japanese (ja)
Other versions
JP7875802B2 (ja
JP2023504560A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/062992 external-priority patent/WO2021113432A1/en
Publication of JP2023504560A publication Critical patent/JP2023504560A/ja
Publication of JP2023504560A5 publication Critical patent/JP2023504560A5/ja
Priority to JP2025165386A priority Critical patent/JP2026017553A/ja
Application granted granted Critical
Publication of JP7875802B2 publication Critical patent/JP7875802B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022533605A 2019-12-03 2020-12-03 ｃ－Ｋｉｔ変異を発現する細胞およびその使用 Active JP7875802B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025165386A JP2026017553A (ja) 2019-12-03 2025-10-01 ｃ－Ｋｉｔ変異を発現する細胞およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962943032P 2019-12-03 2019-12-03
US62/943,032 2019-12-03
PCT/US2020/062992 WO2021113432A1 (en) 2019-12-03 2020-12-03 Cells expressing c-kit mutations and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025165386A Division JP2026017553A (ja) 2019-12-03 2025-10-01 ｃ－Ｋｉｔ変異を発現する細胞およびその使用

Publications (3)

Publication Number Publication Date
JP2023504560A JP2023504560A (ja) 2023-02-03
JP2023504560A5 true JP2023504560A5 (enExample) 2023-12-04
JP7875802B2 JP7875802B2 (ja) 2026-06-18

Family

ID=76222653

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022533605A Active JP7875802B2 (ja) 2019-12-03 2020-12-03 ｃ－Ｋｉｔ変異を発現する細胞およびその使用
JP2025165386A Pending JP2026017553A (ja) 2019-12-03 2025-10-01 ｃ－Ｋｉｔ変異を発現する細胞およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025165386A Pending JP2026017553A (ja) 2019-12-03 2025-10-01 ｃ－Ｋｉｔ変異を発現する細胞およびその使用

Country Status (8)

Country Link
US (1) US20230051518A1 (enExample)
EP (1) EP4069730A4 (enExample)
JP (2) JP7875802B2 (enExample)
CN (1) CN115210254A (enExample)
AU (1) AU2020395175A1 (enExample)
CA (1) CA3163872A1 (enExample)
IL (1) IL293598A (enExample)
WO (1) WO2021113432A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12419913B2 (en) 2019-02-08 2025-09-23 Dna Twopointo, Inc. Modification of CAR-T cells
US20250283041A1 (en) * 2022-05-25 2025-09-11 Albert Einstein College Of Medicine Methods for producing red blood cells
EP4540287A1 (en) * 2022-06-20 2025-04-23 CRISPR Therapeutics AG Chimeric antigen receptor specific to cd117
WO2025117266A2 (en) * 2023-11-27 2025-06-05 Albert Einstein College Of Medicine Method of producing self-renewing erythroid cells from human progenitor cells
CN118725143B (zh) * 2024-07-15 2025-12-02 上海交通大学医学院附属瑞金医院 靶向kit d816v突变衍生抗原的tcr及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005511596A (ja) * 2001-09-20 2005-04-28 アブ サイエンス ヒトの皮膚を白くし、且つメラノサイト機能不全関連疾病を治療するためのチロシンキナーゼ阻害剤の使用方法
US10093701B2 (en) * 2012-09-07 2018-10-09 University Of Miami Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
US10835525B2 (en) * 2012-09-26 2020-11-17 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
WO2015188141A2 (en) * 2014-06-06 2015-12-10 Memorial Sloan-Kettering Cancer Ceneter Mesothelin-targeted chimeric antigen receptors and uses thereof
AU2016274989A1 (en) * 2015-06-12 2017-11-02 Immunomedics, Inc. Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs
AU2017326748A1 (en) * 2016-09-14 2019-04-11 Benitec Biopharma Limited Reagents for producing T-cells with non-functional T-cell receptors (TCRs) compositions comprising same and use thereof
CN109251183A (zh) * 2017-07-13 2019-01-22 广东东阳光药业有限公司 取代脲衍生物的晶型及其在药物中的应用

Similar Documents

Publication Publication Date Title
JP7487112B2 (ja) Ｃｄ１９指向性キメラ抗原受容体および免疫療法におけるその使用
JP7623020B2 (ja) 同種異系移植のための操作された免疫細胞
JP2023502503A5 (enExample)
JP7590034B2 (ja) Ｎｋｇ２ａを標的にする抗体及びその使用
JP2023514148A5 (enExample)
JP2021519061A5 (enExample)
JP2022548943A5 (enExample)
JP2022543742A5 (enExample)
JP2019534246A5 (enExample)
JP2016513458A5 (enExample)
RU2015116901A (ru) Композиции и способы для имуннотерапии
JP2023548467A5 (enExample)
AU2014225788A1 (en) Engager cells for immunotherapy
Dhodapkar et al. Hematologic malignancies: plasma cell disorders
Ahmad et al. PD-L1-specific T cells
JP2023504560A (ja) ｃ－Ｋｉｔ変異を発現する細胞およびその使用
JP2021502828A5 (enExample)
US20230293584A1 (en) Composition and method of use recombinant fusion protein to generate car-immune cells
WO2025093867A1 (en) Invariant natural killer t cell
Li et al. Genetically modified T-cells affinity to tumor cells-development of adoptive T-cell immunotherapy
JP2024543024A5 (enExample)
CN115786268A (zh) 工程化免疫细胞及其用途
US20240148867A1 (en) Methods of treating cancer with a combination of adoptive cell therapy and a targeted immunocytokine
EP4653524A1 (en) Function-enhanced cell therapy
Shamalov et al. Adoptive T-cell immunotherapy: perfecting self-defenses